Both Surgical site infections ( SSIs) and Healthcare acquired infections (HCAIs ) demand a coordinated approach pre-and post-surgery by healthcare professionals and their patients.
Hibiwash® is your trusted partner in helping prevent infections, promote skin’s integrity and save time before performing surgical procedures. It contains 4% Chlorhexidine Gluconate for a wide range of antimicrobial activity and has been used for many decades in hospitals.
Regular use of Hibiwash can help reduce the chance of 11 in 100 patients contracting an SSI up to 30 days after surgery. It has also been shown to significantly decrease the risk of hospital-associated S aureus infections by up to 60% when used in combination with a nasal antibiotic.
Hibiwash is not absorbed into the skin but binds to it to form a protective layer that removes and kills microorganisms and continues to do so for a long period of time after application. Unlike povidone iodine, Hibiwash is not inactivated by bodily fluids.
Hibiwash has been reformulated to be a more sustainable product, using fewer raw materials and less energy in its production. The removal of colour, fragrance and traces of soya oil makes it less likely to create skin irritation or an allergic reaction and has the potential of an increased compliance. It also contains emollients and it is gentle on the skin even with frequent use.